Title:
METHOD FOR TREATING NEPHROLITHIASIS
Document Type and Number:
Japanese Patent JP2013151518
Kind Code:
A
Abstract:
To provide a new and improved medicine for treatment of nephrolithiasis.
Provided is a method using a xanthine oxidoreductase inhibitor or its pharmaceutically acceptable salt. It is desirable that 1-(3-cyano-4-(2,2-dimethyl propoxy)phenyl)-1H-pyrazole-4-carboxylic acid or its pharmaceutically acceptable salt is used.
Inventors:
JOSEPH-RIDGE NANCY
Application Number:
JP2013043914A
Publication Date:
August 08, 2013
Filing Date:
March 06, 2013
Export Citation:
Assignee:
TAKEDA PHARMACEUTICALS USA INC
International Classes:
A61K45/00; A61K31/415; A61P13/12
Domestic Patent References:
| JP2008545627A | 2008-12-18 | |||
| JP2008545627A | 2008-12-18 |
Other References:
JPN6011055000; メルクマニュアル 第１７版 日本語版 , 1999, ｐ．４６４-４６８, 日経ＢＰ社
JPN6011055002; Ｐｒｏｇｒｅｓｓ ｉｎ Ｍｅｄｉｃｉｎｅ 第２４巻，第５号, 2004, ｐ．１２１３-１２１８
JPN6011055005; Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｕｒｏｌｏｇｙ ａｎｄ Ｎｅｐｈｒｏｌｏｇｙ Ｖｏｌ．１５， Ｎｏ．２, 1983, ｐ．１２１-１２９
JPN6014017888; Ｊｏｕｒｎａｌ ｏｆ Ｐｈａｒｍａｃｏｌｏｇｙ ａｎｄ Ｅｘｐｅｒｉｍｅｎｔａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｖｏｌ．３１１， Ｎｏ．２, 2004, ｐ．５１９-５２８
JPN6011055007; Ｄｒｕｇｓ ｏｆ ｔｈｅ Ｆｕｔｕｒｅ Ｖｏｌ．２６， Ｎｏ．１, 2001, ｐ．３２-３８
JPN6011055000; メルクマニュアル 第１７版 日本語版 , 1999, ｐ．４６４-４６８, 日経ＢＰ社
JPN6011055002; Ｐｒｏｇｒｅｓｓ ｉｎ Ｍｅｄｉｃｉｎｅ 第２４巻，第５号, 2004, ｐ．１２１３-１２１８
JPN6011055005; Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｕｒｏｌｏｇｙ ａｎｄ Ｎｅｐｈｒｏｌｏｇｙ Ｖｏｌ．１５， Ｎｏ．２, 1983, ｐ．１２１-１２９
JPN6014017888; Ｊｏｕｒｎａｌ ｏｆ Ｐｈａｒｍａｃｏｌｏｇｙ ａｎｄ Ｅｘｐｅｒｉｍｅｎｔａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｖｏｌ．３１１， Ｎｏ．２, 2004, ｐ．５１９-５２８
JPN6011055007; Ｄｒｕｇｓ ｏｆ ｔｈｅ Ｆｕｔｕｒｅ Ｖｏｌ．２６， Ｎｏ．１, 2001, ｐ．３２-３８
JPN6015017767; Ｄｒｕｇｓ Ｖｏｌ．６４， Ｎｏ．２１, 2004, ｐ．２３９９-２４１６
JPN6016007766; Ａｒｔｈｒｉｔｉｓ ａｎｄ ｒｈｅｕｍａｔｉｓｍ Ｖｏｌ．５２， Ｎｏ．３, 200503, ｐ．９１６-９２３
JPN6016007767; Ｎ． Ｅｎｇｌ． Ｊ． Ｍｅｄ． Ｖｏｌ．３１５， Ｎｏ．２２, 1986, ｐ．１３８６-１３８９
JPN6011055002; Ｐｒｏｇｒｅｓｓ ｉｎ Ｍｅｄｉｃｉｎｅ 第２４巻，第５号, 2004, ｐ．１２１３-１２１８
JPN6011055005; Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｕｒｏｌｏｇｙ ａｎｄ Ｎｅｐｈｒｏｌｏｇｙ Ｖｏｌ．１５， Ｎｏ．２, 1983, ｐ．１２１-１２９
JPN6014017888; Ｊｏｕｒｎａｌ ｏｆ Ｐｈａｒｍａｃｏｌｏｇｙ ａｎｄ Ｅｘｐｅｒｉｍｅｎｔａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｖｏｌ．３１１， Ｎｏ．２, 2004, ｐ．５１９-５２８
JPN6011055007; Ｄｒｕｇｓ ｏｆ ｔｈｅ Ｆｕｔｕｒｅ Ｖｏｌ．２６， Ｎｏ．１, 2001, ｐ．３２-３８
JPN6011055000; メルクマニュアル 第１７版 日本語版 , 1999, ｐ．４６４-４６８, 日経ＢＰ社
JPN6011055002; Ｐｒｏｇｒｅｓｓ ｉｎ Ｍｅｄｉｃｉｎｅ 第２４巻，第５号, 2004, ｐ．１２１３-１２１８
JPN6011055005; Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｕｒｏｌｏｇｙ ａｎｄ Ｎｅｐｈｒｏｌｏｇｙ Ｖｏｌ．１５， Ｎｏ．２, 1983, ｐ．１２１-１２９
JPN6014017888; Ｊｏｕｒｎａｌ ｏｆ Ｐｈａｒｍａｃｏｌｏｇｙ ａｎｄ Ｅｘｐｅｒｉｍｅｎｔａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｖｏｌ．３１１， Ｎｏ．２, 2004, ｐ．５１９-５２８
JPN6011055007; Ｄｒｕｇｓ ｏｆ ｔｈｅ Ｆｕｔｕｒｅ Ｖｏｌ．２６， Ｎｏ．１, 2001, ｐ．３２-３８
JPN6015017767; Ｄｒｕｇｓ Ｖｏｌ．６４， Ｎｏ．２１, 2004, ｐ．２３９９-２４１６
JPN6016007766; Ａｒｔｈｒｉｔｉｓ ａｎｄ ｒｈｅｕｍａｔｉｓｍ Ｖｏｌ．５２， Ｎｏ．３, 200503, ｐ．９１６-９２３
JPN6016007767; Ｎ． Ｅｎｇｌ． Ｊ． Ｍｅｄ． Ｖｏｌ．３１５， Ｎｏ．２２, 1986, ｐ．１３８６-１３８９
Attorney, Agent or Firm:
Kawaguchi International Patent Office
Previous Patent: RELEASE-CONTROL COMPOSITION
Next Patent: AMIDO COMPOUND AND ITS USE AS PHARMACEUTICAL
Next Patent: AMIDO COMPOUND AND ITS USE AS PHARMACEUTICAL